- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x MG: MAGNESIUM ION(Non-covalent)
- 16 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.2: 21 residues within 4Å:- Chain A: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.1, AF3.3, K.4
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:G.40, A:G.92, A:G.92, A:T.93, A:T.94, A:T.95, A:T.95, A:G.404, A:G.405, A:E.490
- Salt bridges: A:K.161
ADP.6: 21 residues within 4Å:- Chain B: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.5, AF3.7, K.8
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:G.40, B:G.92, B:G.92, B:T.93, B:T.94, B:T.95, B:T.95, B:G.404, B:G.405, B:E.490
- Salt bridges: B:K.161
ADP.10: 21 residues within 4Å:- Chain C: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.9, AF3.11, K.12
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:G.40, C:G.92, C:G.92, C:T.93, C:T.94, C:T.95, C:T.95, C:G.404, C:G.405, C:E.490
- Salt bridges: C:K.161
ADP.14: 21 residues within 4Å:- Chain D: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.13, AF3.15, K.16
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:G.40, D:G.92, D:G.92, D:T.93, D:T.94, D:T.95, D:T.95, D:G.404, D:G.405, D:E.490
- Salt bridges: D:K.161
ADP.18: 21 residues within 4Å:- Chain E: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.17, AF3.19, K.20
11 PLIP interactions:11 interactions with chain E- Hydrogen bonds: E:G.40, E:G.92, E:G.92, E:T.93, E:T.94, E:T.95, E:T.95, E:G.404, E:G.405, E:E.490
- Salt bridges: E:K.161
ADP.22: 21 residues within 4Å:- Chain F: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.21, AF3.23, K.24
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:G.40, F:G.92, F:G.92, F:T.93, F:T.94, F:T.95, F:T.95, F:G.404, F:G.405, F:E.490
- Salt bridges: F:K.161
ADP.26: 21 residues within 4Å:- Chain G: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.25, AF3.27, K.28
11 PLIP interactions:11 interactions with chain G- Hydrogen bonds: G:G.40, G:G.92, G:G.92, G:T.93, G:T.94, G:T.95, G:T.95, G:G.404, G:G.405, G:E.490
- Salt bridges: G:K.161
ADP.30: 21 residues within 4Å:- Chain H: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.29, AF3.31, K.32
11 PLIP interactions:11 interactions with chain H- Hydrogen bonds: H:G.40, H:G.92, H:G.92, H:T.93, H:T.94, H:T.95, H:T.95, H:G.404, H:G.405, H:E.490
- Salt bridges: H:K.161
ADP.34: 21 residues within 4Å:- Chain I: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.33, AF3.35, K.36
11 PLIP interactions:11 interactions with chain I- Hydrogen bonds: I:G.40, I:G.92, I:G.92, I:T.93, I:T.94, I:T.94, I:T.95, I:G.404, I:G.405, I:E.490
- Salt bridges: I:K.161
ADP.38: 21 residues within 4Å:- Chain J: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.37, AF3.39, K.40
11 PLIP interactions:11 interactions with chain J- Hydrogen bonds: J:G.40, J:G.92, J:G.92, J:T.93, J:T.94, J:T.94, J:T.95, J:G.404, J:G.405, J:E.490
- Salt bridges: J:K.161
ADP.42: 21 residues within 4Å:- Chain K: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.41, AF3.43, K.44
11 PLIP interactions:11 interactions with chain K- Hydrogen bonds: K:G.40, K:G.92, K:G.92, K:T.93, K:T.94, K:T.94, K:T.95, K:G.404, K:G.405, K:E.490
- Salt bridges: K:K.161
ADP.46: 21 residues within 4Å:- Chain L: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.45, AF3.47, K.48
11 PLIP interactions:11 interactions with chain L- Hydrogen bonds: L:G.40, L:G.92, L:G.92, L:T.93, L:T.94, L:T.94, L:T.95, L:G.404, L:G.405, L:E.490
- Salt bridges: L:K.161
ADP.50: 21 residues within 4Å:- Chain M: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.49, AF3.51, K.52
11 PLIP interactions:11 interactions with chain M- Hydrogen bonds: M:G.40, M:G.92, M:G.92, M:T.93, M:T.94, M:T.94, M:T.95, M:G.404, M:G.405, M:E.490
- Salt bridges: M:K.161
ADP.54: 21 residues within 4Å:- Chain N: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.53, AF3.55, K.56
11 PLIP interactions:11 interactions with chain N- Hydrogen bonds: N:G.40, N:G.92, N:G.92, N:T.93, N:T.94, N:T.94, N:T.95, N:G.404, N:G.405, N:E.490
- Salt bridges: N:K.161
ADP.58: 21 residues within 4Å:- Chain O: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.57, AF3.59, K.60
11 PLIP interactions:11 interactions with chain O- Hydrogen bonds: O:G.40, O:G.92, O:G.92, O:T.93, O:T.94, O:T.94, O:T.95, O:G.404, O:G.405, O:E.490
- Salt bridges: O:K.161
ADP.62: 21 residues within 4Å:- Chain P: T.38, L.39, G.40, P.41, D.91, G.92, T.93, T.94, T.95, G.403, G.404, G.405, L.473, V.475, F.476, M.483, V.488, E.490
- Ligands: MG.61, AF3.63, K.64
11 PLIP interactions:11 interactions with chain P- Hydrogen bonds: P:G.40, P:G.92, P:G.92, P:T.93, P:T.94, P:T.94, P:T.95, P:G.404, P:G.405, P:E.490
- Salt bridges: P:K.161
- 16 x AF3: ALUMINUM FLUORIDE(Non-covalent)
AF3.3: 9 residues within 4Å:- Chain A: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.1, ADP.2
No protein-ligand interaction detected (PLIP)AF3.7: 9 residues within 4Å:- Chain B: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.5, ADP.6
No protein-ligand interaction detected (PLIP)AF3.11: 9 residues within 4Å:- Chain C: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.9, ADP.10
No protein-ligand interaction detected (PLIP)AF3.15: 9 residues within 4Å:- Chain D: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.13, ADP.14
No protein-ligand interaction detected (PLIP)AF3.19: 9 residues within 4Å:- Chain E: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.17, ADP.18
No protein-ligand interaction detected (PLIP)AF3.23: 9 residues within 4Å:- Chain F: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.21, ADP.22
No protein-ligand interaction detected (PLIP)AF3.27: 9 residues within 4Å:- Chain G: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.25, ADP.26
No protein-ligand interaction detected (PLIP)AF3.31: 9 residues within 4Å:- Chain H: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.29, ADP.30
No protein-ligand interaction detected (PLIP)AF3.35: 9 residues within 4Å:- Chain I: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.33, ADP.34
No protein-ligand interaction detected (PLIP)AF3.39: 9 residues within 4Å:- Chain J: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.37, ADP.38
No protein-ligand interaction detected (PLIP)AF3.43: 9 residues within 4Å:- Chain K: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.41, ADP.42
No protein-ligand interaction detected (PLIP)AF3.47: 9 residues within 4Å:- Chain L: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.45, ADP.46
No protein-ligand interaction detected (PLIP)AF3.51: 9 residues within 4Å:- Chain M: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.49, ADP.50
No protein-ligand interaction detected (PLIP)AF3.55: 9 residues within 4Å:- Chain N: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.53, ADP.54
No protein-ligand interaction detected (PLIP)AF3.59: 9 residues within 4Å:- Chain O: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.57, ADP.58
No protein-ligand interaction detected (PLIP)AF3.63: 9 residues within 4Å:- Chain P: D.60, G.61, D.91, G.92, T.93, T.94, K.161
- Ligands: MG.61, ADP.62
No protein-ligand interaction detected (PLIP)- 16 x K: POTASSIUM ION(Non-covalent)
K.4: 5 residues within 4Å:- Chain A: T.38, G.40, N.59, G.160
- Ligands: ADP.2
Ligand excluded by PLIPK.8: 5 residues within 4Å:- Chain B: T.38, G.40, N.59, G.160
- Ligands: ADP.6
Ligand excluded by PLIPK.12: 5 residues within 4Å:- Chain C: T.38, G.40, N.59, G.160
- Ligands: ADP.10
Ligand excluded by PLIPK.16: 5 residues within 4Å:- Chain D: T.38, G.40, N.59, G.160
- Ligands: ADP.14
Ligand excluded by PLIPK.20: 5 residues within 4Å:- Chain E: T.38, G.40, N.59, G.160
- Ligands: ADP.18
Ligand excluded by PLIPK.24: 5 residues within 4Å:- Chain F: T.38, G.40, N.59, G.160
- Ligands: ADP.22
Ligand excluded by PLIPK.28: 5 residues within 4Å:- Chain G: T.38, G.40, N.59, G.160
- Ligands: ADP.26
Ligand excluded by PLIPK.32: 5 residues within 4Å:- Chain H: T.38, G.40, N.59, G.160
- Ligands: ADP.30
Ligand excluded by PLIPK.36: 5 residues within 4Å:- Chain I: T.38, G.40, N.59, G.160
- Ligands: ADP.34
Ligand excluded by PLIPK.40: 5 residues within 4Å:- Chain J: T.38, G.40, N.59, G.160
- Ligands: ADP.38
Ligand excluded by PLIPK.44: 5 residues within 4Å:- Chain K: T.38, G.40, N.59, G.160
- Ligands: ADP.42
Ligand excluded by PLIPK.48: 5 residues within 4Å:- Chain L: T.38, G.40, N.59, G.160
- Ligands: ADP.46
Ligand excluded by PLIPK.52: 5 residues within 4Å:- Chain M: T.38, G.40, N.59, G.160
- Ligands: ADP.50
Ligand excluded by PLIPK.56: 5 residues within 4Å:- Chain N: T.38, G.40, N.59, G.160
- Ligands: ADP.54
Ligand excluded by PLIPK.60: 5 residues within 4Å:- Chain O: T.38, G.40, N.59, G.160
- Ligands: ADP.58
Ligand excluded by PLIPK.64: 5 residues within 4Å:- Chain P: T.38, G.40, N.59, G.160
- Ligands: ADP.62
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yanyan, Z., Cost-benefit analysis of cryogenic electron tomography subtomogram averaging of chaperonin MmCpn at near atomic resolution. To Be Published
- Release Date
- 2025-07-30
- Peptides
- Chaperonin: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
JC
KD
LE
MF
AG
CH
DI
NJ
EK
FL
GM
HN
IO
OP
P
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x MG: MAGNESIUM ION(Non-covalent)
- 16 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 16 x AF3: ALUMINUM FLUORIDE(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yanyan, Z., Cost-benefit analysis of cryogenic electron tomography subtomogram averaging of chaperonin MmCpn at near atomic resolution. To Be Published
- Release Date
- 2025-07-30
- Peptides
- Chaperonin: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
JC
KD
LE
MF
AG
CH
DI
NJ
EK
FL
GM
HN
IO
OP
P